The global Overactive Bladder Treatmentmarket was valued at USD 3.44billion in 2016 and is projected to reach USD 4.43billionby 2025, growing at a CAGR of 2.84% from 2017 to 2025.
An overactive bladder causes a sudden urge to urinate. It can also trigger involuntary loss of urine, known as incontinence. Overactive bladder affects mostly women and geriatric population. The health issue is highly prevalent and the market is expected to grow during the forecast period.
Sample Infographics:
Market Dynamics:
1. Market Drivers
1.1 Improved innovations in Intravesical therapies
1.2 High level marketing by pharma companies
1.3 Increase geriatric population
1.4 Rising number of cases of Diseases Characterized By OAB
2. Market Restraints
2.1 Undesired Systemic Effects of Current OAB Treatments
Market Segmentation:
1. By Disease:
1.1 Idiopathic Overactive Bladder
1.2 Neurogenic Overactive Bladder
1.2.1 Overactive Bladder in Parkinson's Disease
1.2.2 Overactive Bladder in Stroke
1.2.3 Overactive Bladder in Multiple Sclerosis
1.2.4 Overactive Bladder in Spinal Cord Injury
1.2.5 Overactive Bladder in Other Disorders
2. By Pharmacotherapy:
2.1 Anticholinergics
2.1.1 Solifenacin
2.1.2 Oxybutynin
2.1.3 Fesoterodine
2.1.4 Darifenacin
2.1.5 Tolterodine
2.1.6 Trospium
2.1.7 Other Anticholinergics
2.2 Mirabegron
2.3 Botox
2.4 Neurostimulation
2.5 Intravesical Instillation
3. By Region:
3.1 North America (U.S., Canada, Mexico)
3.2 Europe (Germany, UK, France, Rest of Europe)
3.3 Asia Pacific (China, India, Japan, Rest of Asia Pacific)
3.4 Latin America (Brazil, Argentina, Rest of Latin America)
3.5 Middle East & Africa
Competitive Landscape:
The major players in the market are as follows:
1. Astellas Pharma Inc.
2. Pfizer, Inc.
3. Teva Pharmaceutical Industries Limited
4. Allergan, PLC.
5. Mylan N.V.
6. Endo International PLC
7. Hisamitsu Pharmaceutical Co., Inc.
8. Sanofi
9. Aurobindo Pharma Limited
10. Johnson & Johnson
11. Intas Pharmaceuticals Ltd.
12. Apotex Inc.
13. Macleods Pharmaceuticals Ltd.
14. Medtronic PLC
15. Cogentix Medical, Inc.
These major players have adopted various organic as well as inorganic growth strategies such as mergers & acquisitions, new product launches, expansions, agreements, joint ventures, partnerships, and others to strengthen their position in this market.
RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE:
Research study on the Overactive Bladder Treatmentmarketwas performed in five phases which include Secondary research, Primary research, subject matter expert advice, quality check and final review.
The market data was analyzed and forecasted using market statistical and coherent models. Also market shares and key trends were taken into consideration while making the report. Apart from this, other data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Company Market Share Analysis, Standards of Measurement, Top to Bottom Analysis and Vendor Share Analysis.
To know more about the Research Methodology of Verified Market Intelligence and other aspects of the research study, kindly get in touch with our sales team.
1 INTRODUCTION OF GLOBAL OVERACTIVE BLADDER TREATMENTMARKET
1.1 Overview of the Market
1.2 Scope of Report
1.3 Assumptions
2 EXECUTIVE SUMMARY
3 RESEARCH METHODOLOGY OF VERIFIED MARKET INTELLIGENCE
3.1 Data Mining
3.2 Validation
3.3 Primary Interviews
3.4 List of Data Sources
4 GLOBAL OVERACTIVE BLADDER TREATMENTMARKETOUTLOOK
4.1 Overview
4.2 Market Dynamics
4.2.1 Drivers
4.2.2 Restraints
4.2.3 Opportunities
4.3 Porters Five Force Model
4.4 Value Chain Analysis
4.5 Regulatory Framework
5 GLOBAL OVERACTIVE BLADDER TREATMENT MARKET, BY DISEASE
5.1 Idiopathic Overactive Bladder
5.2 Neurogenic Overactive Bladder
5.2.1 Overactive Bladder in Parkinson's Disease
5.2.2 Overactive Bladder in Stroke
5.2.3 Overactive Bladder in Multiple Sclerosis
5.2.4 Overactive Bladder in Spinal Cord Injury
5.2.5 Overactive Bladder in Other Disorders
6 GLOBAL OVERACTIVE BLADDER TREATMENT MARKET, BY PHARMACOTHERAPY
6.1 Anticholinergics
6.1.1 Solifenacin
6.1.2 Oxybutynin
6.1.3 Fesoterodine
6.1.4 Darifenacin
6.1.5 Tolterodine
6.1.6 Trospium
6.1.7 Other Anticholinergics
6.2 Mirabegron
6.3 Botox
6.4 Neurostimulation
6.5 Intravesical Instillation
7 GLOBAL OVERACTIVE BLADDER TREATMENTMARKET, BY GEOGRAPHY
7.1 Overview
7.2 North AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.2.1 U.S.
7.2.2 Canada
7.2.3 Mexico
7.3 EuropeRegional Market Estimates and Forecasts, 2012 - 2025
7.3.1 Germany
7.3.2 U.K.
7.3.3 France
7.3.4 Rest of Europe
7.4 Asia PacificRegional Market Estimates and Forecasts, 2012 - 2025
7.4.1 China
7.4.2 Japan
7.4.3 India
7.4.4 Rest of Asia Pacific
7.5 Latin AmericaRegional Market Estimates and Forecasts, 2012 - 2025
7.5.1 Brazil
7.5.2 Argentina
7.6 Rest of the WorldRegional Market Estimates and Forecasts, 2012 - 2025
8 GLOBAL OVERACTIVE BLADDER TREATMENTMARKETCOMPETITIVE LANDSCAPE
8.1 Overview
8.2 Company Market Share
8.3 Vendor Landscape
8.4 Key Development Strategies
9 COMPANY PROFILES
9.1 Astellas Pharma Inc.
9.1.1 Overview
9.1.2 Financial Performance
9.1.3 Product Outlook
9.1.4 Key Developments
9.2 Pfizer, Inc.
9.2.1 Overview
9.2.2 Financial Performance
9.2.3 Product Outlook
9.2.4 Key Developments
9.3 Teva Pharmaceutical Industries Limited
9.3.1 Overview
9.3.2 Financial Performance
9.3.3 Product Outlook
9.3.4 Key Developments
9.4 Allergan, PLC.
9.4.1 Overview
9.4.2 Financial Performance
9.4.3 Product Outlook
9.4.4 Key Developments
9.5 Mylan N.V.
9.5.1 Overview
9.5.2 Financial Performance
9.5.3 Product Outlook
9.5.4 Key Developments
9.6 Endo International PLC
9.6.1 Overview
9.6.2 Financial Performance
9.6.3 Product Outlook
9.6.4 Key Developments
9.7 Hisamitsu Pharmaceutical Co., Inc.
9.7.1 Overview
9.7.2 Financial Performance
9.7.3 Product Outlook
9.7.4 Key Developments
9.8 Sanofi
9.8.1 Overview
9.8.2 Financial Performance
9.8.3 Product Outlook
9.8.4 Key Developments
9.9 Aurobindo Pharma Limited
9.9.1 Overview
9.9.2 Financial Performance
9.9.3 Product Outlook
9.9.4 Key Development
9.10 Johnson & Johnson
9.10.1 Overview
9.10.2 Financial Performance
9.10.3 Product Outlook
9.10.4 Key Development
9.11 Intas Pharmaceuticals Ltd.
9.11.1 Overview
9.11.2 Financial Performance
9.11.3 Product Outlook
9.11.4 Key Development
9.12 Apotex Inc.
9.12.1 Overview
9.12.2 Financial Performance
9.12.3 Product Outlook
9.12.4 Key Development
9.13 Macleods Pharmaceuticals Ltd.
9.13.1 Overview
9.13.2 Financial Performance
9.13.3 Product Outlook
9.13.4 Key Development
9.14 Medtronic PLC
9.14.1 Overview
9.14.2 Financial Performance
9.14.3 Product Outlook
9.14.4 Key Development
9.15 Cogentix Medical, Inc.
9.15.1 Overview
9.15.2 Financial Performance
9.15.3 Product Outlook
9.15.4 Key Development
10 Appendix
10.1 Related Reports
The Treatment Management System Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Hospital Treatment Fee Evaluation Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Ion Exchange Technology For Water Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive la...
The Comprehensive Wastewater Treatment Service Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Cardiac Stem Cell Treatment Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufac...
The Alcohol Treatment Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape, manufact...
The Substance Abuse Treatment Billing Services Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive lan...
The Waste Gas Treatment System Solutions Market is set to witness immense growth during the forecast period 2024-2031. This intelligence report offers an in-depth analysis of the market size, share, growth, opportunity, competitive landscape...
Market Overview
The Asia Pacific Peritoneal Dialysis Market is projected to experience substantial growth from 2024 to 2034, driven by the rising prevalence of end-stage renal disease (ESRD), advancements in peritoneal dialysis (PD) technologies, and an increasing shift towards home-bas...
Market Overview
The Europe Peritoneal Dialysis Market is projected to experience robust growth from 2024 to 2034, driven by the rising prevalence of chronic kidney disease (CKD) and the increasing adoption of peritoneal dialysis (PD) as a preferred treatment modality. The market is anti...